SMTL ID : 6y9s.2 (1 other biounit)

Crystal structure of GSK-3b in complex with the imidazo[1,5-a]pyridine-3-carboxamide inhibitor 16

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.03 Å

Oligo State

monomer

Ligands

1 x OHK: ~{N}-(oxan-4-ylmethyl)-6-(5-propan-2-yloxypyridin-3-yl)imidazo[1,5-a]pyridine-3-carboxamide(Non-covalent)

OHK.1: 18 residues within 4Å: Chain A: I.28, G.29, F.33, V.36, A.49, K.51, L.98, D.99, Y.100, V.101, P.102, T.104, R.107, Q.151, N.152, L.154, C.165, D.166 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.36, A:A.49, A:L.98, A:Y.100, A:Q.151 Hydrogen bonds: A:V.101, A:V.101

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.2: 5 residues within 4Å: Chain A: R.62, R.146, K.171, N.179, V.180 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:V.180 Hydrogen bonds: A:V.180 Salt bridges: A:R.62, A:R.146, A:K.171

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Buonfiglio, R. et al., Discovery of Novel Imidazopyridine GSK-3 beta Inhibitors Supported by Computational Approaches. Molecules (2020)

Release Date

2020-05-20

Peptides

Glycogen synthase kinase-3 beta: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Glycogen synthase kinase-3 beta

Related Entries With Identical Sequence